A viral protein can be turned into a "killer" of cervical cancer

Researchers at the University of Louis Pasteur in Strasbourg, France, have found that a protein that causes cervical cancer, after a very small mutation, can turn to inhibit the spread of the cancer, which will help scientists develop new drugs for cervical cancer Researchers from the University of Louis Pasteur reported in the electronic edition of the British Journal of oncogenes published on the 17th that 500000 women worldwide suffer from cervical cancer every year, 80% of whom live in developing countries The disease is mainly transmitted through sexual behavior, and the main culprit is human papillomavirus (HPV) According to reports, HPV will produce two kinds of gene proteins, named E6 and E7 respectively Researchers found that E6 causes the proliferation of cancer cells, but when it mutates, it turns to inhibit the generation of tumors The team believes that although the variation is negligible, it can completely change the nature of E6 According to Louis Pasteur University, the main way to treat cervical cancer at present is vaccination, but its price will deter some patients in developing countries In addition, for women who are already sick, the vaccine will not help, so they hope to use the discovery to develop drugs that can treat cervical cancer.